<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>40</CFRTITLE>
    <CFRTITLETEXT>Protection of Environment</CFRTITLETEXT>
    <VOL>30</VOL>
    <DATE>2007-07-01</DATE>
    <ORIGINALDATE>2007-07-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>2-Oxepanone, polymer with 4,4â²-(1-methylethylidene)bisphenol and 2,2-[(1-methylethylidene)bis(4,1-phe-ny-lene-oxy-methyl-ene)]-bi-sox-i- rane, graft.</TITLE>
    <GRANULENUM>721.7160</GRANULENUM>
    <HEADING>Section 721.7160</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 40" SEQ="4">Protection of Environment</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="3">ENVIRONMENTAL PROTECTION AGENCY (CONTINUED)</PARENT>
      <PARENT HEADING="SUBCHAPTER R" SEQ="2">TOXIC SUBSTANCES CONTROL ACT</PARENT>
      <PARENT HEADING="PART 721" SEQ="1">SIGNIFICANT NEW USES OF CHEMICAL SUBSTANCES</PARENT>
      <PARENT HEADING="Subpart E" SEQ="0">Significant New Uses for Specific Chemical Substances</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 721.7160</SECTNO>
    <SUBJECT>2-Oxepanone, polymer with 4,4′-(1-methylethylidene)bisphenol and 2,2-[(1-methylethylidene)bis(4,1-phe-ny-lene-oxy-methyl-ene)]-bi-sox-i- rane, graft.</SUBJECT>
    <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance 2-oxepanone, polymer with 4,4′(1-meth-yl-eth-yli-dene)bi-sphen-ol and 2,2-[(1-meth-yl-eth-yli-dene) bis(4,1-phen-yl-ene-oxy-meth-ylene)]bi-soxi-rane, graft (PMN P-88-2582) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
    <P>(2) The significant new uses are:</P>
    <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i),(a)(5)(ii), (a)(5)(iii), (a)(5)(viii), (a)(5)(ix), (a)(5)(x), (a)(5)(xi), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c).</P>
    <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vi), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5).</P>
    <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (l) and (q).</P>
    <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
    <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (i).</P>
    <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
    <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
    <CITA>[55 FR 33306, Aug. 15, 1990. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
  </SECTION>
</CFRGRANULE>

